Academics lay into drug coupon programs in NEJM:
But their evidence validates, to a degree, industry's claim that coupons are not generics killers
Latest UPS Pain in the (Supply) Chain survey finds product security rising in attention
Regulatory compliance remains the top concern globally, but security and spoilage are high in the Asia/Pacific region
Promotional experimentation and consumer outreach will be available via the Truvio network
New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare
Evidence points to continuing medical value in orphan-drug industry incentives, says Makovsky Health
HDMA leadership remains with David Neu of AmerisourceBergen
CVS Caremark opens a $67-million, 400-employee mail-order pharmacy in Illinois
Highly automated facility can process 50 million prescriptions annually for CVS Caremark's book of business
FedEx, IAG Cargo unveil new cold-chain capabilities
IAG Cargo's Heathrow facility is up and running; FedEx has begun construction of a facility at its Memphis hub
Commercial Data Sources for the Biopharma Industry
A conversation with Michael Swanick, PwC
DME competitive bidding issues: When is enough enough?
Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)
Prime Therapeutics sets the parameters of specialty-drug purchasing discussions
Blue Cross/Blue Shield PBM says seven steps help manage costs
New products, services and businesses appear at Cold Chain Global Forum
Exhibition brings out the latest in temperature-controlled shipping
House passes Drug Quality and Security Act; Senate passage is likely
Bill includes voluntary oversight by FDA of outsourced compounded pharmaceuticals, national distributor licensure, and a timetable for serialization and drug tracking
Manufacturers should step up their monitoring of consumer healthcare choices under Obamacare
The Medicare Part D switchover of 2007 is only a partial proxy for what the healthcare system will experience in the next several years
As the clouds part on Physicians' Sunshine Act, doctors waffle between concern and indifference
Results of a survey panel by QPharma, presented at PDMA Sharing Conference, show a wide spread of reactions and concerns over agg-spend rules
FDA rules for unique device identification (UDI) of medical devices are finalized
UDIs will be in place starting in late 2014, and rolling out over the next four years thereafter
California governor vetoes biosimilar-unfriendly bill
While FDA dithers on regulatory guidance, state efforts to anticipate biosimilar regulation are mostly being rejected
Clinical trial logistics and packaging
The size of clinical trials continues to expand, observers say, creating a ripple effect in pharmaceutical packaging.
CSOs broaden their palette of service offerings
While riding the same downturn as overall pharma sales-rep headcount, contract sales organizations (CSOs) have invested in IT competency and marketing services to meet client needs
The best 'good guys' in pharma distribution
Recent US Supreme Court decisions narrow life-sciences patentability claims
Industry response may be to keep more innovations as trade secrets
The convergence of international and US pricing controls
New approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies
Social media's other challenges
The right supply chain prescription
While pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense
